XML 25 R7.htm IDEA: XBRL DOCUMENT
v3.19.2

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) shares in Millions, $ in Millions | Total | Common Stock | Treasury Stock | Common Stock Including Additional Paid in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | CVS Health Shareholders' Equity | Noncontrolling Interest
--- | --- | --- | --- | --- | --- | --- | --- | ---
Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2017 |  |  | 1,712 | (698) | [1] |  |  |  |  |  |
Balance at beginning of period at Dec. 31, 2017 |  | $ 37,695 |  | $ (37,796) | [1] | $ 32,096 | [2] | $ 43,556 | $ (165) | $ 37,691 | $ 4
Shareholders' Equity [Roll Forward] |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | 998 |  |  |  |  |  | 998 |  | 998 |
Other comprehensive income (loss) |  | 344 |  |  |  |  |  |  | 344 | 344 |
Stock option activity, stock awards and other (in shares) |  |  | 2 |  |  |  |  |  |  |  |
Stock option activity, stock awards and other |  | 112 |  |  |  | 112 | [2] |  |  | 112 |
Purchase of treasury shares, net of ESPP issuances |  | 49 |  | $ 49 | [1] |  |  |  |  | 49 |
Common stock dividends |  | (508) |  |  |  |  |  | (508) |  | (508) |
Shares outstanding, balance at end of period (in shares) at Mar. 31, 2018 |  |  | 1,714 | (698) | [1] |  |  |  |  |  |
Balance at end of period at Mar. 31, 2018 |  | 38,677 |  | $ (37,747) | [1] | 32,208 | [2] | 44,040 | 172 | 38,673 | 4
Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2017 |  |  | 1,712 | (698) | [1] |  |  |  |  |  |
Balance at beginning of period at Dec. 31, 2017 |  | 37,695 |  | $ (37,796) | [1] | 32,096 | [2] | 43,556 | (165) | 37,691 | 4
Shareholders' Equity [Roll Forward] |  |  |  |  |  |  |  |  |  |  |
Other comprehensive income (loss) |  | 313 |  |  |  |  |  |  | 313 |  |
Shares outstanding, balance at end of period (in shares) at Jun. 30, 2018 |  |  | 1,716 | (699) | [1] |  |  |  |  |  |
Balance at end of period at Jun. 30, 2018 |  | 35,611 |  | $ (37,780) | [1] | 32,281 | [2] | 40,965 | 141 | 35,607 | 4
Shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2018 |  |  | 1,714 | (698) | [1] |  |  |  |  |  |
Balance at beginning of period at Mar. 31, 2018 |  | 38,677 |  | $ (37,747) | [1] | 32,208 | [2] | 44,040 | 172 | 38,673 | 4
Shareholders' Equity [Roll Forward] |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | (2,563) |  |  |  |  |  | (2,563) |  | (2,563) |
Other comprehensive income (loss) |  | (31) |  |  |  |  |  |  | (31) | (31) |
Stock option activity, stock awards and other (in shares) |  |  | 2 |  |  |  |  |  |  |  |
Stock option activity, stock awards and other |  | 73 |  |  |  | 73 | [2] |  |  | 73 |
Purchase of treasury shares, net of ESPP issuances (in shares) | [1] |  |  | (1) |  |  |  |  |  |  |
Purchase of treasury shares, net of ESPP issuances |  | (33) |  | $ (33) | [1] |  |  |  |  | (33) |
Common stock dividends |  | (512) |  |  |  |  |  | (512) |  | (512) |
Shares outstanding, balance at end of period (in shares) at Jun. 30, 2018 |  |  | 1,716 | (699) | [1] |  |  |  |  |  |
Balance at end of period at Jun. 30, 2018 |  | 35,611 |  | $ (37,780) | [1] | 32,281 | [2] | 40,965 | 141 | 35,607 | 4
Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2018 |  |  | 1,720 | (425) | [3] |  |  |  |  |  |
Balance at beginning of period at Dec. 31, 2018 |  | 58,543 |  | $ (28,228) | [3] | 45,440 | [4] | 40,911 | 102 | 58,225 | 318
Shareholders' Equity [Roll Forward] |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | 1,427 |  |  |  |  |  | 1,421 |  | 1,421 | 6
Other comprehensive income (loss) |  | 331 |  |  |  |  |  |  | 331 | 331 |
Stock option activity, stock awards and other (in shares) |  |  | 2 |  |  |  |  |  |  |  |
Stock option activity, stock awards and other |  | 175 |  |  |  | 175 | [4] |  |  | 175 |
Purchase of treasury shares, net of ESPP issuances (in shares) | [3] |  |  | 1 |  |  |  |  |  |  |
Purchase of treasury shares, net of ESPP issuances |  | 7 |  | $ 7 | [3] |  |  |  |  | 7 |
Common stock dividends |  | (651) |  |  |  |  |  | (651) |  | (651) |
Other decreases in noncontrolling interests |  | (4) |  |  |  |  |  |  |  |  | (4)
Shares outstanding, balance at end of period (in shares) at Mar. 31, 2019 |  |  | 1,722 | (424) | [3] |  |  |  |  |  |
Balance at end of period at Mar. 31, 2019 |  | 60,006 |  | $ (28,221) | [3] | 45,615 | [4] | 41,859 | 433 | 59,686 | 320
Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2018 |  |  | 1,720 | (425) | [3] |  |  |  |  |  |
Balance at beginning of period at Dec. 31, 2018 |  | 58,543 |  | $ (28,228) | [3] | 45,440 | [4] | 40,911 | 102 | 58,225 | 318
Shareholders' Equity [Roll Forward] |  |  |  |  |  |  |  |  |  |  |
Other comprehensive income (loss) |  | 582 |  |  |  |  |  |  | 582 |  |
Shares outstanding, balance at end of period (in shares) at Jun. 30, 2019 |  |  | 1,724 | (425) | [3] |  |  |  |  |  |
Balance at end of period at Jun. 30, 2019 |  | 61,599 |  | $ (28,257) | [3] | 45,719 | [4] | 43,136 | 684 | 61,282 | 317
Shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2019 |  |  | 1,722 | (424) | [3] |  |  |  |  |  |
Balance at beginning of period at Mar. 31, 2019 |  | 60,006 |  | $ (28,221) | [3] | 45,615 | [4] | 41,859 | 433 | 59,686 | 320
Shareholders' Equity [Roll Forward] |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | 1,931 |  |  |  |  |  | 1,936 |  | 1,936 | (5)
Other comprehensive income (loss) |  | 251 |  |  |  |  |  |  | 251 | 251 |
Stock option activity, stock awards and other (in shares) |  |  | 2 |  |  |  |  |  |  |  |
Stock option activity, stock awards and other |  | 104 |  |  |  | 104 | [4] |  |  | 104 |
Purchase of treasury shares, net of ESPP issuances (in shares) | [3] |  |  | (1) |  |  |  |  |  |  |
Purchase of treasury shares, net of ESPP issuances |  | (36) |  | $ (36) | [3] |  |  |  |  | (36) |
Common stock dividends |  | (659) |  |  |  |  |  | (659) |  | (659) |
Other decreases in noncontrolling interests |  | 2 |  |  |  |  |  |  |  |  | 2
Shares outstanding, balance at end of period (in shares) at Jun. 30, 2019 |  |  | 1,724 | (425) | [3] |  |  |  |  |  |
Balance at end of period at Jun. 30, 2019 |  | $ 61,599 |  | $ (28,257) | [3] | $ 45,719 | [4] | $ 43,136 | $ 684 | $ 61,282 | $ 317
[1] | Treasury shares include 1 million shares held in trust as of June 30, 2018, March 31, 2018 and December 31, 2017. Treasury stock includes $31 million related to shares held in trust as of June 30, 2018, March 31, 2018 and December 31, 2017.
[2] | Common stock and capital surplus includes the par value of common stock of $17 million as of June 30, 2018, March 31, 2018 and December 31, 2017.
[3] | Treasury shares include 1 million shares held in trust as of June 30, 2019, March 31, 2019 and December 31, 2018. Treasury stock includes $29 million related to shares held in trust as of June 30, 2019, March 31, 2019 and December 31, 2018.
[4] | Common stock and capital surplus includes the par value of common stock of $17 million as of June 30, 2019, March 31, 2019 and December 31, 2018.

X
- Definition Noncontrolling interest, Other Period Increase (Decrease) + References No definition available. + Details
Name: | cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease
Namespace Prefix: | cvs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance + References No definition available. + Details
Name: | cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
Namespace Prefix: | cvs_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance + References No definition available. + Details
Name: | cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
Namespace Prefix: | cvs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 405 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817 + Details
Name: | us-gaap_DividendsCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. + References No definition available. + Details
Name: | us-gaap_IncreaseDecreaseInStockholdersEquityRollForward
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section S99 -Paragraph 3A -Subparagraph (3) -URI http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764 + Details
Name: | us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after tax and reclassification adjustments of other comprehensive income (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 55 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580 + Details
Name: | us-gaap_OtherComprehensiveIncomeLossNetOfTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares issued which are neither cancelled nor held in the treasury. + References No definition available. + Details
Name: | us-gaap_SharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of share options (or share units) exercised during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of stock issued as a result of the exercise of stock options. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4I -URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683 + Details
Name: | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant